Diplomat Pharmacy (DPLO) Tops Q2 EPS by 2c

August 9, 2016 4:40 PM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Diplomat Pharmacy (NYSE: DPLO) reported Q2 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.12 billion.


Diplomat Pharmacy sees FY2016 EPS of $0.90-$0.95, versus prior guidance of $0.88-$0.95 and the consensus of $0.93. Diplomat Pharmacy sees FY2016 revenue of $4.5-4.9 billion, versus the consensus of $4.76 billion.

For earnings history and earnings-related data on Diplomat Pharmacy (DPLO) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment